"Japan's success in digital health is attributed to the collaborative efforts between the government, private sector, and academic institutions"

Could you elaborate on some of the most prominent trends shaping the landscape of clinical trials in the Asia-Pacific re...

May 20, 2024 | Monday | News
The Antibody-Drug Conjugate Community in Asia is Gearing Up for Their Annual Industry Touchpoint

Making its triumphant return to the region this Summer, this meeting will bring together key players of the ADC lan...

May 15, 2024 | Wednesday | News
Singapore's SMART researchers identify malaria parasite drug resistance mechanism

Researchers from the Antimicrobial Resistance (AMR) Interdisciplinary Research Group (IRG) at Singapore-M...

May 17, 2024 | Friday | News
“Australia offers a simple, supportive and robust regulatory process to initiate human trials efficiently”

What makes Uvax Bio’s technology different from other vaccine technologies?  Recombinant protein vaccines ar...

May 1, 2024 | Wednesday | Opinion
“Regulatory encouragement of advanced tech, including AI will accelerate clinical trials in APAC”

Could you elaborate on the most prominent trends shaping the APAC clinical trials landscape? One of Lokavant’s ea...

May 1, 2024 | Wednesday | Opinion
What Are the Main Challenges of Modern Clinical Trials?

While the increasing volume of clinical data is welcome in many respects, clinicians and trial managers often struggle w...

May 1, 2024 | Wednesday | Opinion
How APAC Has Turned into Clinical Trial Behemoth

Over the past decade, the Asia-Pacific (APAC) region has emerged as a global leader in clinical trial conduct. In 2021, ...

May 1, 2024 | Wednesday | Opinion
What’s APAC’s Recipe of Success in Clinical Trials Market?

The APAC region continues to rule the roost in clinical trials, experiencing dramatic growth rates surpassing those in t...

May 1, 2024 | Wednesday | Analysis
QUT partners with Omico to pave way for precision cancer care in Australia

Australian Translational Genomics Centre (ATGC) at Queensland University of Technology (QUT) will help link Queensland...

April 22, 2024 | Monday | News
Singapore supports development of AI-based clinical trial tool with S$50,000

A team of healthcare professionals has received a $50,000 award to transform their idea for an Artificial Intelligence (...

March 27, 2024 | Wednesday | News
ClinChoice acquires CSI, expanding global footprint into Southeast Asia

ClinChoice, a global Contract Research Organisation (CRO), has announced expanding its global footprint with the acquisi...

January 12, 2024 | Friday | News
CEPI, IVI and MRC Unit The Gambia to bolster clinical research capacity in West Africa to combat regional viral threat

The Coalition for Epidemic Preparedness Innovations (CEPI), the Republic of Korea-based International Vaccine Institute ...

November 30, 2023 | Thursday | News
Japanese firm Mitsui invests $8 M in US-based clinical intelligence startup Lokavant

US-based Lokavant, the clinical trial intelligence platform company, has announced an $8 million strategic investment fr...

October 10, 2023 | Tuesday | News
Buzzreach and Oncoshot spearhead clinical trial advancements in Japan

Buzzreach and Oncoshot, two prominent entities in the clinical trials domain, have announced an impactful collaboration ...

September 14, 2023 | Thursday | News
Australia shines in clinical trial activity ranking but gaps exist

An examination of how clinical trials have changed in Australia over the past 15 years has identified challenges such as...

August 18, 2023 | Friday | News
Why India Is Most Preferred Clinical Trials Destination

According to a February 2022 report by Research and Markets, the clinical trials market in India was estimated to be val...

July 4, 2023 | Tuesday | Opinion
Immuno-oncology company Biosyngen opens new cell therapy GMP facility in Singapore

Biosyngen, an immuno-oncology company with technology targeting the unmet medical needs in solid tumour and lymphoma tre...

June 28, 2023 | Wednesday | Company results
Australian startup Cyteph secures $1.5 M for brain cancer immunotherapy trial

Cyteph, a spin-out biotechnology company from QIMR Berghofer Medical Research Institute in Australia, has been awa...

May 30, 2023 | Tuesday | News